Description

CAS Number: 2632576-96-3
Molecular Formula: C₂₉₈H₄₇₀N₈₂O₈₃
Molecular Weight: 6937.57 g/mol
Purity: ≥99% (HPLC Certified)
AKA: LY3437943; Triple Agonist

R3 is a synthetic peptide engineered as a triple agonist of the glucagon-like peptide-1 receptor, glucose-dependent insulinotropic polypeptide (GIP) receptor, and glucagon receptor (GCGR). This multi-pathway receptor activation is of significant interest in metabolic research for its potential to influence energy expenditure, glucose regulation, and adipose tissue metabolism.

In vitro and preclinical studies evaluate R3’s effect on appetite signaling, insulin sensitivity, hepatic fat reduction, and lipid mobilization. Its interaction with GCGR provides additional research value in models examining thermogenesis, enhanced fat oxidation, and metabolic rate modulation beyond traditional incretin pathways.

R3 is widely studied in research exploring multi-receptor incretin mimetics, metabolic disease modeling, and advanced body-weight regulation mechanisms, particularly due to its robust activity across three key hormonal systems.

• • • • • • • • • • • • • • • PLEASE READ • • • • • • • • • • • • • • •

RESEARCH USE ONLY DISCLAIMER AND LIMITATION OF LIABILITY

All articles, materials, content, and product-related information made available on this website are provided strictly for informational and educational purposes only and shall not be construed as medical, pharmaceutical, clinical, or therapeutic advice, nor as a representation of safety or efficacy for any human or animal use.

These products are not drugs, pharmaceuticals, biologics, medical devices, dietary supplements, food products, or cosmetics, and they have not been evaluated, approved, or authorized by the United States Food and Drug Administration (FDA) or any other regulatory authority for human or animal use.

The Company reserves all rights and expressly disclaims any liability arising from misuse, improper handling, or unauthorized application of its products.